Ghent University Academic Bibliography

PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : acute toxicity of a randomized phase 2 trial

Piet Ost (UGent) , Shankar Siva, Sigmund Brabrand, Piet Dirix, Nick Liefhooghe, François-Xavier Otte, Alfonso Gomez-Iturriaga, Wouter Everaerts, Mohamed Shelan, Antonio Conde-Moreno, et al.

(2024) EUROPEAN UROLOGY ONCOLOGY.

Add to list

Journal Article
A1
open access

International consensus guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy : update from an IBIS workgroup

Flor Verghote (UGent) , Paul Sargos, John P. Christodouleas, Vedang Murthy, Brian C. Baumann, Piet Dirix, Charlien Berghen, Leen Paelinck (UGent) , Tom Vercauteren (UGent) and Valerie Fonteyne (UGent)

(2022) PRACTICAL RADIATION ONCOLOGY. 12(6). p.524-532

Add to list

Can medical imaging identify the histopathological growth patterns of liver metastases?

Emily Latacz, Pieter-Jan van Dam, Christian Vanhove (UGent) , Laura Llado, Benedicte Descamps (UGent) , Núria Ruiz, Ines Joye, Dirk Grünhagen, Steven Van Laere, Piet Dirix, et al.

(2021) SEMINARS IN CANCER BIOLOGY. 71. p.33-41

Add to list

Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial

Mathieu Spaas (UGent) , Nora Sundahl, Sylvie Rottey (UGent) , VIBEKE KRUSE (UGent) , Daan De Maeseneer (UGent) , Fréderic Duprez (UGent) , Piet Dirix, Veerle Surmont (UGent) , Yolande Lievens (UGent) , Robin Van den Begin, et al.

(2021) ESTRO 2021, Abstracts. 161(S1). p.S490-S491

Add to list

Journal Article
A1
open access

Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC) : a phase II prospective trial

Flor Verghote (UGent) , Lindsay Poppe (UGent) , Sofie Verbeke (UGent) , Piet Dirix, Maarten Albersen, Gert De Meerleer, Charlien Berghen, Piet Ost (UGent) , Geert Villeirs (UGent) , Pieter De Visschere (UGent) , et al.

(2021) BMC CANCER. 21(1).

Add to list

Journal Article
A1
open access

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial

Mathieu Spaas (UGent) , Nora Sundahl, Eva Hulstaert, Vibeke Kruse (UGent) , Sylvie Rottey (UGent) , Daan De Maeseneer (UGent) , Veerle Surmont (UGent) , Annabel Meireson (UGent) , Lieve Brochez (UGent) , Dries Reynders (UGent) , et al.

(2021) BMC CANCER. 21(1).

Add to list

Miscellaneous
open access

The multicenter, randomized, phase 2 PEACE V-STORM trial : defining the best salvage treatment for oligorecurrent nodal prostate cancer metastases

Thomas Zilli, Piet Dirix, Reino Heikkila, Nick Liefhooghe, Shankar Siva, Alfonso Gomez-Iturriaga, Wouter Everaerts, Francois Otte, Mohamed Shelan, Carole Mercier, et al.

(2021) EUROPEAN UROLOGY FOCUS. 7(2). p.241-244

Add to list

Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy

Piet Dirix, Michiel Strijbos, Tom Van den Mooter, Nick Liefhooghe, Siska Van Bruwaene, Pieter Uvin, Christophe Ghysel, Dieter Ost, Peter Schatteman, Samuel Bral, et al.

(2020) FUTURE ONCOLOGY. 16(16). p.1083-1089

Add to list

Journal Article
A1
open access

A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)

Carole Mercier, Piet Dirix, Piet Ost (UGent) , Charlotte Billiet, Ines Joye, Peter Vermeulen, Yolande Lievens (UGent) and Dirk Verellen

(2019) BMC CANCER. 19(1).

Add to list

Oligometastatic prostate cancer : the game is afoot

Andrea Lancia, Thomas Zilli, Verane Achard, Piet Dirix, Wouter Everaerts, Alfonso Gomez-Iturriaga, Gianluca Ingrosso, Nick Liefhooghe, Raymond Miralbell, Shankar Siva, et al.

(2019) CANCER TREATMENT REVIEWS. 73. p.84-90

Add to list

Journal Article
A1
open access

PRIMMO study protocol : a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer

Sandra Tuyaerts, An MT Van Nuffel, Eline Naert (UGent) , Peter A Van Dam, Peter Vuylsteke, Alex De Caluwé, Sandrine Aspeslagh, Piet Dirix, Lien Lippens (UGent) , Emiel De Jaeghere (UGent) , et al.

(2019) BMC CANCER. 19.

Add to list

Journal Article
A2
open access

Introducing a castrate resistant prostate cancer (CRPC) model care pathway in Belgian hospitals : towards national standardization?

Tijl Vermassen (UGent) , Thierry Roumeguere, Yannick Neybuch, Lucien Hoekx, Irena Fele, Brieuc Sautois, Wouter Everaerts, Daan De Maeseneer (UGent) , Frederic Lecouvet, Nicolaas Lumen (UGent) , et al.

(2019) BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 13(6). p.219-226

Add to list

Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer : a multi-institutional analysis comparing the outcome and toxicity of stereotactic body radiotherapy and elective nodal radiotherapy

Elise De Bleser, Barbara Alicja Jereczek-Fossa, David Pasquier, Thomas Zilli, Nicholas Van As, Andrei Fodor, Piet Dirix, Alfonso Gomez-Iturriaga, Fabio Trippa, Shankar Siva, et al.

(2019) EUROPEAN UROLOGY. 76(6). p.732-739

Add to list

PRIMMO study : combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer

Sandra Tuyaerts, An Van Nuffel, Peter Van Dam, Peter Vuylsteke, Alex De Caluwé, Piet Dirix, Katrien Vandecasteele (UGent) and Hannelore Denys (UGent)

(2017) Cancer Immunotherapy, 3rd CRI-CIMT-EATI-AACR international conference, Abstracts.

Add to list

Journal Article
A1
open access

Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer : a phase II trial

Valerie Fonteyne (UGent) , Piet Dirix, Sara Junius, Elke Rammant (UGent) , Piet Ost (UGent) , Gert De Meerleer, Martijn Swimberghe (UGent) and Karel Decaestecker (UGent)

(2017) BMC CANCER. 17.

Academic Bibliography

PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : acute toxicity of a randomized phase 2 trial

International consensus guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy : update from an IBIS workgroup

Can medical imaging identify the histopathological growth patterns of liver metastases?

Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial

Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC) : a phase II prospective trial

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial

The multicenter, randomized, phase 2 PEACE V-STORM trial : defining the best salvage treatment for oligorecurrent nodal prostate cancer metastases

Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy

A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)

Oligometastatic prostate cancer : the game is afoot

PRIMMO study protocol : a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer

Introducing a castrate resistant prostate cancer (CRPC) model care pathway in Belgian hospitals : towards national standardization?

Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer : a multi-institutional analysis comparing the outcome and toxicity of stereotactic body radiotherapy and elective nodal radiotherapy

PRIMMO study : combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer

Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer : a phase II trial

Contents

Support

Contact